DOES LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVEL CORRELATE WITH INSULIN RESISTANCE STATES IN METABOLIC SYNDROME, AN EARLY ATHEROSCLEROTIC PHASE?

Sağun G., Mesci B. , OĞUZ A.

ACTA ENDOCRINOLOGICA-BUCHAREST, vol.7, no.2, pp.199-207, 2011 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 2
  • Publication Date: 2011
  • Doi Number: 10.4183/aeb.2011.199
  • Title of Journal : ACTA ENDOCRINOLOGICA-BUCHAREST
  • Page Numbers: pp.199-207

Abstract

Background. Lipoprotein-associated phospholipase A2 is a novel inflammation marker that generates pro-inflammatory molecules from oxidized LDL.